[go: up one dir, main page]

FI862124L - MORFINDERS. - Google Patents

MORFINDERS. Download PDF

Info

Publication number
FI862124L
FI862124L FI862124A FI862124A FI862124L FI 862124 L FI862124 L FI 862124L FI 862124 A FI862124 A FI 862124A FI 862124 A FI862124 A FI 862124A FI 862124 L FI862124 L FI 862124L
Authority
FI
Finland
Prior art keywords
morfinders
Prior art date
Application number
FI862124A
Other languages
Finnish (fi)
Other versions
FI862124A7 (en
FI862124A0 (en
Inventor
Laszlo Revesz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI862124A0 publication Critical patent/FI862124A0/en
Publication of FI862124A7 publication Critical patent/FI862124A7/en
Publication of FI862124L publication Critical patent/FI862124L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI862124A 1985-05-23 1986-05-21 MORFINDERS. FI862124L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3518525 1985-05-23

Publications (3)

Publication Number Publication Date
FI862124A0 FI862124A0 (en) 1986-05-21
FI862124A7 FI862124A7 (en) 1986-11-24
FI862124L true FI862124L (en) 1986-11-24

Family

ID=6271435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862124A FI862124L (en) 1985-05-23 1986-05-21 MORFINDERS.

Country Status (18)

Country Link
JP (1) JPS61271275A (en)
AU (1) AU594954B2 (en)
BE (1) BE904796A (en)
DK (1) DK240386A (en)
ES (1) ES8802318A1 (en)
FI (1) FI862124L (en)
FR (1) FR2582309B1 (en)
GB (1) GB2175898B (en)
GR (1) GR861318B (en)
HU (1) HU196376B (en)
IL (1) IL78872A0 (en)
IT (1) IT1203791B (en)
LU (1) LU86435A1 (en)
NL (1) NL8601188A (en)
NZ (1) NZ216250A (en)
PH (1) PH23341A (en)
SE (1) SE8602308L (en)
ZA (1) ZA863873B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
JP2906654B2 (en) * 1989-11-28 1999-06-21 東レ株式会社 Immunosuppressant and method for producing the same
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
US6323212B1 (en) * 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications
JP3948026B2 (en) * 1993-07-19 2007-07-25 東レ株式会社 Brain cell protectant
AU686203B2 (en) * 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
AR005423A1 (en) 1996-01-10 1999-06-23 Smithkline Beecham Spa MORPHINOID DERIVATIVES CONDENSED WITH HETERO CYCLES (II), THEIR USE AS A THERAPEUTIC SUBSTANCE AND TO PREPARE MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE TO PREPARE SUCH DERIVATIVES.
EP1310251A1 (en) * 1996-11-25 2003-05-14 Toray Industries, Inc. Antipruritic agent
WO1999005146A1 (en) * 1997-07-25 1999-02-04 Toray Industries, Inc. Hyponatremia remedies
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
WO2003097608A2 (en) 2002-05-17 2003-11-27 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP4957489B2 (en) * 2002-10-09 2012-06-20 東レ株式会社 Pharmaceutical containing morphinan derivative having nitrogen-containing cyclic substituent or pharmacologically acceptable acid addition salt thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP2011512360A (en) * 2008-02-14 2011-04-21 アルカーメス,インコーポレイテッド Selective opioid compounds
JP6141444B2 (en) * 2012-12-14 2017-06-07 パーデュー、ファーマ、リミテッド、パートナーシップ Spirocyclic morphinans and their use
JP6100917B2 (en) * 2012-12-14 2017-03-22 パーデュー、ファーマ、リミテッド、パートナーシップ Biological activity on pyridone morphinan analogues and opioid receptors.
AR096851A1 (en) * 2013-07-11 2016-02-03 H Lundbeck As SALTS THAT DO NOT FORM HYDRATS OR SOLVATOS DE NALMEFENO
JP6360915B2 (en) * 2014-06-13 2018-07-18 パーデュー、ファーマ、リミテッド、パートナーシップ Azamorphinan derivatives and uses thereof

Also Published As

Publication number Publication date
AU5763786A (en) 1986-11-27
IT8648050A0 (en) 1986-05-23
FI862124A7 (en) 1986-11-24
FR2582309B1 (en) 1989-08-18
JPS61271275A (en) 1986-12-01
GB8612159D0 (en) 1986-06-25
ES8802318A1 (en) 1988-05-01
IL78872A0 (en) 1986-09-30
NZ216250A (en) 1990-04-26
GB2175898A (en) 1986-12-10
ES555200A0 (en) 1988-05-01
AU594954B2 (en) 1990-03-22
NL8601188A (en) 1986-12-16
GB2175898B (en) 1989-07-05
HU196376B (en) 1988-11-28
ZA863873B (en) 1988-01-27
SE8602308L (en) 1986-11-24
DK240386D0 (en) 1986-05-22
FI862124A0 (en) 1986-05-21
HUT41737A (en) 1987-05-28
FR2582309A1 (en) 1986-11-28
BE904796A (en) 1986-11-21
GR861318B (en) 1986-09-19
DK240386A (en) 1986-11-24
SE8602308D0 (en) 1986-05-21
LU86435A1 (en) 1986-12-05
IT1203791B (en) 1989-02-23
PH23341A (en) 1989-07-14

Similar Documents

Publication Publication Date Title
FI873652A0 (en) TRAFIKKONTROLLSYSTEM.
FI862124L (en) MORFINDERS.
FI850549A0 (en) PLANTERINGSREDSKAP FOER PLANTOR.
FI863114A0 (en) EN PAPPERSMASKINS INLOPPSLAODA.
FI851763A0 (en) HYDRAULISKT KLASSIFISERINGSFOERFARANDE OCH -ANORDNING.
FI863739A0 (en) ISBRYTARE.
FI862398L (en) BIS-MALEINIMIDSAMMANSAETTNING.
NO862828D0 (en) SENGETOEY.
FI854688L (en) POLYAMIDHALTIG MAONGSKIKTSFILM.
FI863920L (en) KOPPLINGSNORDNING FOER EN ELEKTRONISK AVSKILJINGSKOPPLING.
FI850220L (en) SKIVPRESS.
FI851052A0 (en) NOSKAPINSALT.
FI852020L (en) SKARV FOER BETONGPAOLAR.
FI851987A0 (en) BITTORVSMASKIN.
FI852100L (en) BLANDNINGS- OCH MATNINGSMEDEL.
FI851663A0 (en) SKAKNINGSDAEMPARE.
NO157517C (en) PROEVETAKER.
FI850436A0 (en) BYGGNADSPROFILSYSTEM SPECIELLT FOER LJUSTAKKONSTRUKTIONER.
FI853806A0 (en) VISITKORT.
FI852783L (en) VAERMEPANNA.
FI851526A0 (en) KUGGVAEXEL.
FI851766L (en) NIBBLINGSMASKIN.
FI852021A0 (en) VAEXELRIKTAT TVINNINGSFOERFARANDE OCH -ANORDNING.
FI850222A0 (en) SKYDDSHJAELM.
FI850558A0 (en) LYFTBOGGI.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG